Literature DB >> 1372260

CD59 expressed by human endothelial cells functions as a protective molecule against complement-mediated lysis.

R A Brooimans1, A A Van der Ark, M Tomita, L A Van Es, M R Daha.   

Abstract

CD59 is a 18-20-kDa membrane glycoprotein that inhibits formation of the membrane attack complex of complement (C) on homologous cells. In the present study we analyzed the expression and function of CD59 on human endothelial cells. Immunohistochemical analysis of renal cortex demonstrated a predominant expression of CD59 on peritubular capillary endothelial cells and glomerular endothelial cells. Flow cytometry analysis showed that human umbilical vein endothelial cells (HUVEC) expressed CD59 and the fluorescence intensity was approximately four times that of peripheral blood lymphocytes. CD59 is detected on sodium dodecyl sulfate-polyacrylamide gel electrophoresis as a single 20-kDa molecule in 2% deoxycholate extracts of HUVEC. CD59 was released from the surface of HUVEC by phosphatidylinositol-specific phospholipase C, demonstrating that it is attached to the cell membrane by means of a glycolipid anchor. The functional activity of CD59 expressed on HUVEC was studied. Blocking of CD59 antigen with F(ab')2 fragments of polyclonal anti-CD59 enhanced markedly the susceptibility of HUVEC to C-mediated lysis. This effect was dependent on the amount of blocking antibodies added. Northern blot analysis revealed the presence of three species of mRNA expressed in HUVEC, which hybridized to a cDNA probe specific for CD59, with sizes of about 800, 1400 and 2000 bp. These findings suggest that CD59 may be important in protection of endothelial cells against C-mediated damage at local sites of inflammation, thereby maintaining the vascular integrity in vivo.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1372260     DOI: 10.1002/eji.1830220324

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  14 in total

Review 1.  Membrane defence against complement lysis: the structure and biological properties of CD59.

Authors:  A Davies; P J Lachmann
Journal:  Immunol Res       Date:  1993       Impact factor: 2.829

2.  Binding of human and rat CD59 to the terminal complement complexes.

Authors:  T Lehto; B P Morgan; S Meri
Journal:  Immunology       Date:  1997-01       Impact factor: 7.397

Review 3.  Membrane proteins that protect against complement lysis.

Authors:  B P Morgan; S Meri
Journal:  Springer Semin Immunopathol       Date:  1994

4.  Human and rodent decay-accelerating factors (CD55) are not species restricted in their complement-inhibiting activities.

Authors:  C L Harris; O B Spiller; B P Morgan
Journal:  Immunology       Date:  2000-08       Impact factor: 7.397

5.  Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC?

Authors:  B E Ballieux; K T Zondervan; P Kievit; E C Hagen; L A van Es; F J van der Woude; M R Daha
Journal:  Clin Exp Immunol       Date:  1994-07       Impact factor: 4.330

6.  Complement regulatory proteins in early human fetal life: CD59, membrane co-factor protein (MCP) and decay-accelerating factor (DAF) are differentially expressed in the developing liver.

Authors:  K L Simpson; J M Houlihan; C H Holmes
Journal:  Immunology       Date:  1993-10       Impact factor: 7.397

Review 7.  Endothelial cells in allograft rejection.

Authors:  Rafia S Al-Lamki; John R Bradley; Jordan S Pober
Journal:  Transplantation       Date:  2008-11-27       Impact factor: 4.939

8.  Functional activity of the membrane-associated complement inhibitor CD59 in a pig-to-human in vitro model for hyperacute xenograft rejection.

Authors:  B Heckl-Ostreicher; R Binder; M Kirschfink
Journal:  Clin Exp Immunol       Date:  1995-12       Impact factor: 4.330

Review 9.  Complement-mediated injury and protection of endothelium: lessons from atypical haemolytic uraemic syndrome.

Authors:  Heather Kerr; Anna Richards
Journal:  Immunobiology       Date:  2011-07-30       Impact factor: 3.144

10.  Soluble CD59 in peritoneal dialysis: a potential biomarker for peritoneal membrane function.

Authors:  Bernardo Faria; Mariana Gaya da Costa; Carla Lima; Loek Willems; Ricardo Brandwijk; Stefan P Berger; Mohamed R Daha; Manuel Pestana; Marc A Seelen; Felix Poppelaars
Journal:  J Nephrol       Date:  2020-12-11       Impact factor: 3.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.